1650-M15
1650-M15 is an inhibitor of lipoteichoic acid synthase (LtaS) . It has inhibitory activity against Gram-positive bacteria but has no significant inhibitory effect against Gram-negative bacteria. The IC50s of 1650-M15 against MRSA and MSSA are 62.44 μM and 66.42 μM, respectively, and the MICs are both 200 μM[1].
Product Specifications
CAS Number
[850935-88-5]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/1650-m15.html
Purity
99.33
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(S(=O)(N2CCCCC2C)=O)C=C1)NC3=NN=C(C4CC4)O3
Molecular Formula
C18H22N4O4S
Molecular Weight
390.46
References & Citations
[1]Methods and compositions for inhibiting gram positive bacteria. United States, US20150246024 A1, 2015-09-03.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PLK1, CT (PLK1, PLK, Serine/threonine-protein kinase PLK1, Polo-like kinase 1, Serine/threonine-protein kinase 13) (MaxLight 405)
PLK1, CT (PLK1, PLK, Serine/threonine-protein kinase PLK1, Polo-like kinase 1, Serine/threonine-protein kinase 13) (MaxLight 405)